Multifunctional Compounds for Activation of the p53-Y220C Mutant in Cancer

Chemistry : a European Journal
Jessica J MillerTim Storr

Abstract

The p53 protein plays a major role in cancer prevention, and over 50 % of cancer diagnoses can be attributed to p53 malfunction. The common p53 mutation Y220C causes local protein unfolding, aggregation, and can result in a loss of Zn in the DNA-binding domain. Structural analysis has shown that this mutant creates a surface site that can be stabilized using small molecules, and herein a multifunctional approach to restore function to p53-Y220C is reported. A series of compounds has been designed that contain iodinated phenols aimed for interaction and stabilization of the p53-Y220C surface cavity, and Zn-binding fragments for metallochaperone activity. Their Zn-binding affinity was characterized using spectroscopic methods and demonstrate the ability of compounds L4 and L5 to increase intracellular levels of Zn2+ in a p53-Y220C-mutant cell line. The in vitro cytotoxicity of our compounds was initially screened by the National Cancer Institute (NCI-60), followed by testing in three stomach cancer cell lines with varying p53 status', including AGS (WTp53), MKN1 (V143A), and NUGC3 (Y220C). Our most promising ligand, L5, is nearly 3-fold more cytotoxic than cisplatin in a large number of cell lines. The impressive cytotoxicity of ...Continue Reading

References

Jul 2, 1992·Nature·D P Lane
Jul 5, 1991·Science·M HollsteinC C Harris
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·A N BullockA R Fersht
Oct 26, 2000·Nature·M O Hengartner
Dec 1, 2000·Nature·B VogelsteinA J Levine
Oct 14, 2005·Journal of Medicinal Chemistry·Richard Morphy, Zoran Rankovic
Apr 6, 2006·Biochemical Pharmacology·Xinying WangMarie Chia-mi Lin
Sep 23, 2006·Nature Reviews. Cancer·Robert H Shoemaker
Jan 27, 2007·Cancer Chemotherapy and Pharmacology·Henk M W VerheulRoberto Pili
Aug 28, 2007·Cell·Kenneth M Yamada, Edna Cukierman
Oct 20, 2007·Expert Review of Anticancer Therapy·Dexin Zhang, Daiming Fan
Dec 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Olivier Rixe, Tito Fojo
Apr 24, 2008·Nature Reviews. Molecular Cell Biology·Todd RileyArnold Levine
Jul 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Frank M BoecklerAlan R Fersht
Oct 29, 2008·Oncogene·E C PietschM E Murphy
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Cornelis J Van der Schyf, Moussa B H Youdim
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Henry SilverMoussa Youdim
Jan 13, 2010·Cold Spring Harbor Perspectives in Biology·Jack T Zilfou, Scott W Lowe
Feb 26, 2010·Cold Spring Harbor Perspectives in Biology·Magali OlivierPierre Hainaut
May 18, 2010·Molecular Cell·Katharina SchlerethThorsten Stiewe
Nov 13, 2010·Metallomics : Integrated Biometal Science·Stewart N Loh
Dec 7, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jung-Suk ChoiMi Hee Lim
May 4, 2011·Progress in Neurobiology·Werner J GeldenhuysCornelis J Van der Schyf
Feb 14, 2012·Pharmaceutical Statistics·J L Sebaugh
Mar 24, 2012·Journal of the American Chemical Society·Rainer WilckenFrank M Boeckler
Mar 29, 2012·Journal of the American Chemical Society·Anuj K SharmaLiviu M Mirica
May 26, 2012·Cancer Cell·Xin YuDarren R Carpizo
Jul 4, 2012·Cell Cycle·Gabriella D'Orazi, David Givol
Aug 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·GuoZhen Wang, Alan R Fersht
Aug 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·Rainer WilckenAlan R Fersht
Sep 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sören LehmannPer-Ola Andersson
Oct 18, 2012·Drug Discovery Today·Susan Breslin, Lorraine O'Driscoll
Dec 25, 2012·Nature Cell Biology·Patricia A J Muller, Karen H Vousden
May 1, 2013·Nucleic Acids Research·Xiangrui LiuAlan R Fersht
Sep 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Giorgio GagliaGalit Lahav

❮ Previous
Next ❯

Citations

Feb 15, 2020·Chemical Science·Jessica J MillerTim Storr
Aug 18, 2021·The Journal of Physical Chemistry. B·Yiming TangGuanghong Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.